Search

Srinivas T Palakodaty

from Foster City, CA
Age ~60
Get Report
Also known as:
Srinivas X Palakodaty, Sprinivas T Palakodaty
Phone and address:
Goldhunter Ct, San Mateo, CA 94404
Related to:
Sirisha Palakodaty, 55
Connected to:
Neelima Palakonda, 73Pradeep Palaksha, 48Sanjay A Palakshappa, 38Arun R Palakurthy, 43Peter Palal, 79Alex Palamara, 38Andrew W Palamar, 77Andriy Palamar, 46Arthur E Palamara, 80Eliana E Palamara, 32

Srinivas Palakodaty Phones & Addresses

  • Goldhunter Ct, Foster City, CA 94404
  • Upland, CA
  • 115 Goldhunter Ct, Foster City, CA 94404

Work

Company: Gilead sciences 2007 Position: Associate director, manufacturing

Education

Degree: High school graduate or higher

Industries

Pharmaceuticals

Resumes

Resumes

Srinivas Palakodaty Photo 1

Director, Manufacturing At Gilead Sciences

View page
Location:
199 east Blaine St, Seattle, WA 98109
Industry:
Pharmaceuticals
Work:
Gilead Sciences since 2007
Associate Director, Manufacturing

Publications

Us Patents

Compositions Comprising Amphotericin B, Methods, And Systems

View page
US Patent:
7326691, Feb 5, 2008
Filed:
Jun 21, 2005
Appl. No.:
11/158332
Inventors:
Sarma Duddu - Redwood City CA, US
Srinivas Palakodaty - Foster City CA, US
Danforth Miller - San Carlos CA, US
Alan R. Kugler - Montara CA, US
Christopher Frantz - Sunnyvale CA, US
Trixie Tan - Daly City CA, US
Richard Malcolmson - San Mateo CA, US
Keith Washco - Fremont CA, US
Theresa Sweeney - El Granada CA, US
Thomas E. Tarara - Burlingame CA, US
Sarvajna Dwivedi - Redwood City CA, US
Michael A. Eldon - Redwood City CA, US
Assignee:
Nektar Therapeutics - San Carlos CA
International Classification:
A61K 9/14
A61K 31/70
US Classification:
514 31, 536 65, 424489
Abstract:
A composition includes particles including at least about 95 wt % of amphotericin B, wherein the particles have a mass median diameter ranging from about 1. 1 μm to about 1. 9 μm. Another composition also includes particles including at least about 95 wt % of amphotericin B, wherein at least about 80 wt % of the particles have a geometric diameter ranging from about 1. 1 μm to about 1. 9 μm. Yet another composition includes particles including amphotericin B, wherein the particles have a mass median diameter less than about 1. 9 μm, and wherein the amphotericin B has a crystallinity level of at least about 20%. Unit dosage forms, delivery systems, and methods may involve similar compositions.

Particle Formation

View page
US Patent:
20030109421, Jun 12, 2003
Filed:
Jul 17, 2002
Appl. No.:
10/197689
Inventors:
Srinivas Palakodaty - Foster City CA, US
Andreas Kordikowski - Skipton, GB
Darren Gilbert - Shipley, GB
International Classification:
A61K038/00
B01J013/02
US Classification:
514/002000, 264/004100
Abstract:
Method for preparing a target substance in particulate form, comprising introducing into a particle formation vessel, through separate first and second fluid inlets respectively, (a) a “target solution/suspension” of the substance in a fluid vehicle and (b) a compressed fluid anti-solvent, and allowing the anti-solvent to extract the vehicle so as to form particles of the substance, wherein the anti-solvent fluid has a sonic, near-sonic or supersonic velocity as it enters the vessel, and wherein the anti-solvent and the target solution/suspension enter the vessel at different locations and meet downstream (in the direction of anti-solvent flow) of the second fluid inlet. Also provided is apparatus for use in such a method.

Stable Non-Crystalline Formulation Comprising Losartan

View page
US Patent:
20060160871, Jul 20, 2006
Filed:
Dec 6, 2005
Appl. No.:
11/296108
Inventors:
Srinivas Palakodaty - Foster City CA, US
Jiang Zhang - Palo Alto CA, US
Andreas Kordikowski - Bingley, GB
Linda Daintree - Todmorden, GB
Sarma Duddu - Redwood City CA, US
Alan Kugler - Montara CA, US
Herm Snyder - Pacifica CA, US
Nagesh Palepu - Mill Creek WA, US
Michael Eldon - Redwood City CA, US
Assignee:
Nektar Therapeutics - San Carlos CA
International Classification:
A61K 31/4184
US Classification:
514381000
Abstract:
One or more embodiments of the invention provide various novel formulations, and tablet dosage forms, comprising losartan that are non-crystalline, stable, and/or otherwise improvements over known losartan formulations. One or more embodiments of the invention further provide methods for preparing the formulation, methods for preparing the tablet dosage form, and to methods of administering the tablet dosage and/or formulation comprising losartan. The losartan-containing formulations may be administered to a user to treat hypertension, and related conditions.

Particle Formation

View page
US Patent:
20060279011, Dec 14, 2006
Filed:
May 3, 2006
Appl. No.:
11/416640
Inventors:
Srinivas Palakodaty - Foster City CA, US
Andreas Kordikowski - Sent Cugat del Valles, ES
Darren Gilbert - Bradford, GB
International Classification:
B29B 9/00
US Classification:
264011000
Abstract:
Method for preparing a target substance in particulate form, comprising introducing into a particle formation vessel, through separate first and second fluid inlets respectively, (a) a “target solution/suspension” of the substance in a fluid vehicle and (b) a compressed fluid anti-solvent, and allowing the anti-solvent to extract the vehicle so as to form particles of the substance, wherein the anti-solvent fluid has a sonic, near-sonic or supersonic velocity as it enters the vessel, and wherein the anti-solvent and the target solution/suspension enter the vessel at different locations and meet downstream (in the direction of anti-solvent flow) of the second fluid inlet. Also provided is apparatus for use in such a method.

Particle Formation

View page
US Patent:
20060280823, Dec 14, 2006
Filed:
May 3, 2006
Appl. No.:
11/416641
Inventors:
Srinivas Palakodaty - Foster City CA, US
Andreas Kordikowski - Sant Cugat del Velles, ES
Darren Gilbert - Bradford, GB
International Classification:
B29B 9/00
US Classification:
425007000
Abstract:
Method for preparing a target substance in particulate form, comprising introducing into a particle formation vessel, through separate first and second fluid inlets respectively, (a) a “target solution/suspension” of the substance in a fluid vehicle and (b) a compressed fluid anti-solvent, and allowing the anti-solvent to extract the vehicle so as to form particles of the substance, wherein the anti-solvent fluid has a sonic, near-sonic or supersonic velocity as it enters the vessel, and wherein the anti-solvent and the target solution/suspension enter the vessel at different locations and meet downstream (in the direction of anti-solvent flow) of the second fluid inlet. Also provided is apparatus for use in such a method.

Powder Conditioning Of Unit Dose Drug Packages

View page
US Patent:
20100287884, Nov 18, 2010
Filed:
Oct 23, 2008
Appl. No.:
12/738607
Inventors:
Sangita Seshadri - Saratoga CA, US
Barry Fong - San Lorenzo CA, US
Srinivas Palakodaty - Foster City CA, US
Concordio Candug Anacleto - Daly City CA, US
Patrick Reich - San Jose CA, US
Andrew John Boeckl - Amsterdam, NL
Derrick J. Parks - Belmont CA, US
Gordon Stout - El Cerrito CA, US
International Classification:
A61M 15/00
B65B 1/22
US Classification:
53437, 53525, 12820312
Abstract:
The invention provides techniques for treating or conditioning powders subsequent to their packaging to facilitate extraction of the powders from their packaging.
Control profile
Srinivas T Palakodaty from Foster City, CA, age ~60 Get Report